News release: Renishaw drug delivery system to be used in Parkinsons trial (docx)

File size: 45 kB Language: English Part number: H-4149-0098

News release: Renishaw drug delivery system to be used in Parkinsons trial

Renishaw’s novel drug delivery system, to be used in partnership with Herantis Pharma Plc’s drug candidate CDNF for the treatment of Parkinson’s disease, is about to enter phase 1-2 clinical trials. The study will be supported by a €6 million grant from Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

This type of file requires a viewer, freely available from Microsoft

Latest videos - Neurological products

Latest items - Neurological products

Email me when this file is updated

Didn't find what you were looking for?

tell us what you couldn’t find and we will do our best to help